BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noble J, Metzger A, Naciri Bennani H, Daligault M, Masson D, Terrec F, Imerzoukene F, Bardy B, Fiard G, Marlu R, Chevallier E, Janbon B, Malvezzi P, Rostaing L, Jouve T. Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation. J Clin Med 2021;10:1316. [PMID: 33806743 DOI: 10.3390/jcm10061316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Naciri Bennani H, Marlu R, Terrec F, Motte L, Seyve L, Chevallier E, Malvezzi P, Jouve T, Rostaing L, Noble J. How to improve clotting factors depletion in double-filtration plasmapheresis. J Clin Apher 2021. [PMID: 34339059 DOI: 10.1002/jca.21928] [Reference Citation Analysis]
2 Chen YY, Sun X, Huang W, He FF, Zhang C. Therapeutic apheresis in kidney diseases: an updated review. Ren Fail 2022;44:842-57. [PMID: 35723077 DOI: 10.1080/0886022X.2022.2073892] [Reference Citation Analysis]
3 Weinhard J, Noble J, Jouve T, Malvezzi P, Rostaing L. Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review. J Clin Med 2021;10:4359. [PMID: 34640377 DOI: 10.3390/jcm10194359] [Reference Citation Analysis]